The FRESH Study: Treatment of Intracranial Aneurysms with the New FRED X Flow Diverter with Antithrombotic Surface Treatment Technology—First Multicenter Experience in 161 Patients

^aFrom the Department of Neuroradiology (D.F.V., M.B., M.A.M.), Heidelberg University Hospital, Heidelberg, Germany
^bDepartment of Neuroradiology (H.L., A.D.), University of Erlangen-Nuremberg, Erlangen, Germany
^cDepartment of Clinical Neurosciences (J.D., S. Gatt), Royal Infirmary of Edinburgh, Edinburgh, UK
^dDepartment of Neuroradiology (M.S., S. Gasser), Johannes Kepler University Linz, Linz, Austria
^eDepartment of Diagnostic and Interventional Neuroradiology (C.M., A.B.), University Hospital Augsburg, Augsburg, Germany
^fDepartment of Radiology (N.K.), Division of Neuroradiology, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Turkey
^gDepartment of Neurology (M.K.-O.), Institute of Neurointervention, Paracelsus Medizinische Privatuniversität, Salzburg, Austria
^hDepartment of Interventional Radiology (R.R.), Turku University Hospital, Turku, Finland
ⁱDepartment of Neuroradiology (L.V.), San Carlo Borromeo Hospital, Milano, Lombardia, Italy

Please address correspondence to Markus A. Möhlenbruch, MD, Department of Neuroradiology, Heidelberg University Hospital, INF 400, 69120 Heidelberg, Germany; e-mail: markus.moehlenbruch{at}med.uni-heidelberg.de